From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

Congress Passes Pandemic All-Hazard Preparedness Act

by Global Biodefense Staff
January 22, 2013

The U.S. House of Representatives today approved the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013, H.R. 307. The legislation, introduced by Rep. Mike Rogers (R-MI), reauthorizes provisions of the Project Bioshield Act of 2004 and Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006 for an additional five years.

H.R. 307 continues to strengthen the nation’s preparedness infrastructure and support development of medical countermeasures to better respond to chemical, biological, radiological, and nuclear attacks.

The bill was brought to vote under a suspension of House rules, a common practice for bills expected to easily obtain at least a two-thirds majority, allowing just 40 minutes of debate prior to a vote. 

Energy and Commerce Committee Chairman Fred Upton (R-MI) said, “I would like to thank Rep. Rogers along with all the other members who worked on this bipartisan bill that will improve the nation’s health infrastructure to help us respond to a terrorist attack and provide additional flexibility for emergency distribution, stockpiling and use of medical countermeasures to ensure the nation is prepared for public health emergencies. As the nation grapples with a severe flu season, the need to pass this legislation is ever more apparent.”

The vote passed by an overwhelming 91 percent majority. Voting against H.R. 307 were 29 House Republicans. No House Democrats voted against the bill.

The full text of H.R. 307 is available here.

From Our Partners
Tags: Emerging ThreatsPandemic

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates
Public Health

Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates

May 31, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC